60 results
Page 3 of 3
F-1
EX-10.13
eyd5oty
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
uh9e ka1g
24 Jun 19
Registration statement (foreign)
4:04pm
6-K
EX-99.1
cswqlm i74
5 Jun 19
Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer
2:43pm
6-K
EX-99.1
yyq3vg6guif s4mbgwa
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.3
92fv662hqk20a95h
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.1
52eg6g
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
20-F
jcubz04wsy1
25 Feb 19
Annual report (foreign)
5:08pm
20-F
EX-4.13
12b 9ridjgn6bx
25 Feb 19
Annual report (foreign)
5:08pm
6-K
EX-99.1
gimgk9 6b216u
25 Feb 19
Gamida Cell Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
4:15pm
6-K
EX-99.1
szw5bcxgr7lky
21 Feb 19
Current report (foreign)
2:06pm
6-K
EX-99.1
wnxm9pwdw0rxl7qe51jw
19 Feb 19
Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
2:05pm
DRS
5wuycashcablu5jy
15 Feb 19
Draft registration statement
12:00am
6-K
EX-99.1
pih96hv6cz
8 Feb 19
Current report (foreign)
9:50am
6-K
EX-99.1
ggza5pe g2uweu
25 Jan 19
Gamida Cell Announces Data from NAM-NK and NiCord® Programs to Be Presented at 2019 TCT Annual Meeting
12:22pm
6-K
EX-99.1
2r8i od8i89g8vlmb167
7 Jan 19
Gamida Cell Announces 2019 Goals and Provides Company Update
4:25pm
424B4
wrzubvz
30 Oct 18
Prospectus supplement with pricing info
8:35am
F-1/A
k5mlz 6zj9
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1
77ppstm0sk7j
28 Sep 18
Registration statement (foreign)
4:29pm
DRS/A
syi7hiykdin9
3 Jul 18
Draft registration statement (amended)
12:00am
DRS
3125dv1soua zsl
1 Jun 18
Draft registration statement
12:00am